Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$5.2 million.

  • Tandem Diabetes Care's Change in Inventory rose 4992.29% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.8 million, marking a year-over-year decrease of 31968.24%. This contributed to the annual value of -$5.8 million for FY2024, which is 11261.59% down from last year.
  • Latest data reveals that Tandem Diabetes Care reported Change in Inventory of -$5.2 million as of Q3 2025, which was up 4992.29% from -$2.5 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Change in Inventory ranged from a high of $19.9 million in Q1 2023 and a low of -$10.4 million during Q3 2024
  • In the last 5 years, Tandem Diabetes Care's Change in Inventory had a median value of $3.0 million in 2021 and averaged $3.7 million.
  • In the last 5 years, Tandem Diabetes Care's Change in Inventory surged by 714957.98% in 2022 and then plummeted by 22101.52% in 2024.
  • Over the past 5 years, Tandem Diabetes Care's Change in Inventory (Quarter) stood at $3.0 million in 2021, then soared by 78.24% to $5.4 million in 2022, then soared by 147.48% to $13.3 million in 2023, then plummeted by 104.46% to -$595000.0 in 2024, then tumbled by 772.94% to -$5.2 million in 2025.
  • Its Change in Inventory was -$5.2 million in Q3 2025, compared to -$2.5 million in Q2 2025 and -$9.6 million in Q1 2025.